De Intinis, Carlo
Bodini, Margherita
Maffione, Denise
De Mot, Laurane
Coccia, Margherita
Medini, Duccio
Siena, Emilio
Funding for this research was provided by:
GlaxoSmithKline
Article History
Received: 11 June 2021
Accepted: 24 September 2021
First Online: 21 October 2021
Competing interests
: Carlo De Intinis is a PhD student at the University of Turin, with a scholarship from GlaxoSmithKline Biologicals SA. DMa participated in a GSK sponsored PhD program at the time of the study. LDM participated in a GSK sponsored postdoctoral scholar at the time of the study. DMe was an employee of GSK group of companies at the time of the study. ES, MB and MC are all employees of the GSK group of companies. The clinical study was independently conducted by the National Institute of Health (NIH), in accordance with the Declaration of Helsinki. The study is registered on ExternalRef removed with the reference ID NCT01191853. Data was collected from the Gene Expression Omnibus public database (Accession ID: GSE47353).